Prestige Consumer Healthcare Inc. Earnings Per Share Disclosure
Year Ended March 31, | |||||||||||
(In thousands, except per share data) | 2017 | 2016 | 2015 | ||||||||
Numerator | |||||||||||
Net income | $ | 69,395 | $ | 99,907 | $ | 78,260 | |||||
Denominator | |||||||||||
Denominator for basic earnings per share - weighted average shares outstanding | 52,976 | 52,754 | 52,170 | ||||||||
Dilutive effect of unvested restricted stock units and options issued to employees and directors | 386 | 389 | 500 | ||||||||
Denominator for diluted earnings per share | 53,362 | 53,143 | 52,670 | ||||||||
Earnings per Common Share: | |||||||||||
Basic net earnings per share | $ | 1.31 | $ | 1.89 | $ | 1.50 | |||||
Diluted net earnings per share | $ | 1.30 | $ | 1.88 | $ | 1.49 | |||||
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2017 | May 17, 2017 | Showing above |
| 2016 | May 17, 2016 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.